CECOG Academy

www.cecog.org

 

Post SABCS Webinar
25:58

CECOG Academy

SABCS Updates on Targeting Mutations in MBC Treatment: PIK3CA, AKT & HER2 Mutations and Available Therapies

FEATURING Leticia De Mattos-Arruda
  • 124 views
  • March 29, 2021
16:33

CECOG Academy

SABCS Updates on CDK4/6i in HR+, HER2- EBC: Is It Time to Adopt in Adjuvant Setting?

FEATURING Evandro de Azambuja
  • 183 views
  • March 29, 2021
  • 1
15:56

CECOG Academy

Immune CPIs in mTNBC: What, When and Where?

FEATURING Evandro de Azambuja
  • 131 views
  • March 29, 2021
25:24

CECOG Academy

SABCS Updates on TNBC: Chemotherapy, Biomarkers, PARPi, AKTi, CDK4/6i, Sacituzumab Govitecan, Neoadjuvant Atezolizumab & Pembrolizumab

FEATURING Rupert Bartsch
  • 184 views
  • March 29, 2021
  • 2